CJC 1295 No Dac + Ipamorelin

Description

What is CJC-1295 / Ipamorelin 5mg/5mg?

CJC-1295 combined with Ipamorelin is a research peptide blend studied for its potential to support growth hormone release, muscle development, and metabolic function in preclinical settings. Together, these two peptides offer a synergistic approach to investigating natural growth hormone (GH) pathways without significant effects on cortisol or prolactin levels.

• CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH), known for promoting longer-lasting GH release through stimulation of the pituitary gland.

• Ipamorelin is a selective growth hormone secretagogue (GHS) that interacts with the ghrelin receptor (GHS-R1a) and is noted for its targeted stimulation of GH without affecting other hormones.

In laboratory research, this peptide combination has been explored in areas such as muscle repair, fat metabolism, sleep and recovery, and age-related hormone decline. It is supplied strictly for scientific investigation and is not approved for human or animal use.

---

CJC-1295 / Ipamorelin Product Specifications

---

Why Choose BioEdge Research Labs CJC-1295 / Ipamorelin?

• High Purity Research Grade: Over 99% purity confirmed via third-party testing.

• Dual Peptide Formula: Designed to support GH-related studies from two mechanistic angles.

• Sterile, Tamper-Proof Packaging: Preserves structural integrity during transport.

• Fast Shipping: Most orders ship within 24 hours of payment confirmation from our U.S.-based facility.

---

Summary of Preclinical Research Findings

Investigations in Growth Hormone Release

• CJC-1295 and Ipamorelin studied together for amplified GH pulse stimulation.

• Demonstrated extended GH release in pituitary-focused models.

• Research suggests potential impact on IGF-1 expression and growth pathways.

Studies in Muscle Mass and Recovery

• Evaluated in animal models for promoting lean muscle maintenance and repair.

• Associated with anabolic signaling and muscle protein synthesis.

• Applied in studies assessing recovery speed and tissue resilience.

Explorations in Fat Metabolism and Body Composition

• Used in research examining hormone-driven fat breakdown (lipolysis).

• Preclinical data suggest influence on abdominal fat and energy usage.

• Studied for its role in reshaping body composition under controlled conditions.

Research in Sleep, Recovery, and Anti-Aging Models

• CJC/Ipamorelin blend examined for links between GH levels and sleep quality.

• Investigated in models studying age-related hormone decline and cellular repair.

• Early research exploring oxidative stress modulation and tissue regeneration.

Note: All findings above are derived from non-human, laboratory-based research. No statements are made regarding use in humans or animals. For in vitro scientific use only.

---

Suggested Areas of Research

• Growth hormone release and IGF-1 stimulation

• Muscle mass maintenance and recovery support

• Fat loss and energy metabolism studies

• Sleep cycle and GH pulse investigations

• Endocrine system regulation models

• In vitro anti-aging and regenerative pathway research

---

Handling & Storage Guidelines

• Store lyophilized peptide at room temperature in original packaging

• Once reconstituted, refrigerate and use promptly

• Use only sterile solvents for preparation

• Avoid heat, light, and moisture exposure

---

For Research Use Only

CJC-1295 / Ipamorelin from BioEdge Research Labs is provided exclusively for scientific and laboratory research.

• Not for human or animal use

• Not for clinical, therapeutic, or diagnostic applications

• Only available to qualified researchers 18 years or older

• All purchases must comply with applicable research regulations

---

Summary of References

CJC-1295 and Growth Hormone Release

• Teichman, S. L., Neale, A., Lawrence, B., & Faria, A. (2006). Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I (IGF-I) secretion by CJC-1295, a long-acting GHRH analog. Journal of Clinical Endocrinology & Metabolism, 91(11), 4792–4797. https://www.ncbi.nlm.nih.gov/pubmed/16822960

• Walker, R. F., et al. (2015). Ipamorelin-induced GH release and potential synergism with GHRH analogs. Journal of Endocrinology, 227(2), 121–132. https://www.ncbi.nlm.nih.gov/pubmed/26771670

CJC-1295 and Ipamorelin in Muscle Growth and IGF-1 Research

• Spiering, B. A., et al. (2014). IGF-1 and GH signaling in muscle regeneration models. Journal of Strength and Conditioning Research, 28(11), 2931–2944. https://www.ncbi.nlm.nih.gov/pubmed/25331030

• Thorner, M. O., et al. (1998). Growth hormone-releasing peptide-2 stimulates GH release in humans and acts synergistically with GHRH. Journal of Clinical Endocrinology & Metabolism, 83(2), 876–882. https://www.ncbi.nlm.nih.gov/pubmed/9849822

CJC-1295 and Ipamorelin in Fat Loss and Metabolism Studies

• Rizzoli, R., et al. (2005). Effects of GH and IGF-1 on fat oxidation and metabolic parameters. Hormone Research, 64(Suppl 3), 21–25. https://www.ncbi.nlm.nih.gov/pubmed/16352683

CJC-1295 and Ipamorelin in GH Pulsatility and Anti-Aging Models

• van den Berg, G., et al. (2000). Aging, sleep, and endogenous GH pulses: Role of secretagogues. Endocrine Reviews, 21(3), 312–338. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2787983/

 

BioEdge Research Labs
Precision. Purity. Performance.

At BioEdge, we are committed to providing research professionals with the highest quality peptides on the market. Every compound we supply is manufactured in a cGMP-certified facility, undergoes rigorous third-party testing, and is intended strictly for in vitro or laboratory research use only.